Marlyn Nutraceuticals, Inc. v. Improvita Health Products

663 F. Supp. 2d 841, 2009 U.S. Dist. LEXIS 95869, 2009 WL 3188416
CourtDistrict Court, D. Arizona
DecidedSeptember 30, 2009
DocketCV-08-1798-PHX-MHM
StatusPublished
Cited by6 cases

This text of 663 F. Supp. 2d 841 (Marlyn Nutraceuticals, Inc. v. Improvita Health Products) is published on Counsel Stack Legal Research, covering District Court, D. Arizona primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Marlyn Nutraceuticals, Inc. v. Improvita Health Products, 663 F. Supp. 2d 841, 2009 U.S. Dist. LEXIS 95869, 2009 WL 3188416 (D. Ariz. 2009).

Opinion

ORDER

MARY H. MURGUIA, District Judge.

Currently before the Court are Defendants Thomas Klamet and Daniel Kohler’s Motion For Judgement on the Pleadings pursuant to Rule 12(c) of the Federal Rules of Civil Procedure. In the same motion, these Defendants also request that the Court dismiss Plaintiffs claims for lack of personal jurisdiction pursuant to Rule 12(b)(2) of the Federal Rules of Civil Procedure. After reviewing the pleadings and determining that oral argument is unnecessary, the Court issues the following order.

I. BACKGROUND:

On May 15, 2007, Plaintiff MNI and Defendant Improvita entered into a Manufacturing and Supply Agreement (the “Agreement”) pursuant to which MNI would manufacture and supply nutritional products and supplements to Improvita. (Dkt. #1, ¶ 10). The Agreement provides that all disputes must be resolved through an arbitration process pursuant to Article XVIII, entitled “Dispute Resolution.” (Dkt. # 11, Ex. B). The Agreement provides that Improvita will pay MNI for all finished product or work in process, and all unused ingredients that can not be returned. (Dkt. # 11, ¶ 11). Improvita fell behind on payments; from approximately October 2007 through late February 2008, MNI attempted to work with Improvita with respect to its delinquent debts. (Id., ¶ 14). On February 29, 2008, due to Improvita’s failure to pay down its debts and alleged attempt to delay resolving the payment issues, MNI initiated negotiation proceedings pursuant to the Agreement’s notice provision in Article XVIII. (Id., ¶ 19). MNI’s February 29, 2008 notice demanded that Improvita agree to formally mediate the payment dispute on or before the close of business on March 5, 2008. (Id., ¶ 21). MNI also provided names of potential mediators in Phoenix, Arizona, and approximately eight possible dates on which the parties could mediate. (Id.). Improvita failed to respond to MNI’s request until March 4, 2008. (M, ¶ 20, Ex. C).

Having made no progress through alternative dispute resolution, MNI filed a Complaint against Improvita in Maricopa *845 County Superior Court on March 20, 2008. (Dkt. # 11, ¶ 23). Improvita subsequently filed a Motion to Dismiss, arguing that the dispute must be resolved through mediation or arbitration based on the alternative dispute resolution provision in the May 15, 2007 Agreement. (Id). MNI did not file a responsive memorandum to Defendants’ Motion to Dismiss, and the Superior Court dismissed the case. (Id, ¶ 24).

On May 19, 2008, MNI and Improvita submitted to a mediation in Phoenix, Arizona. (Dkt. # 11, ¶ 24). In preparation for the mediation, MNI submitted a 13 page Mediation Memorandum, including 25 exhibits; Improvita made no settlement offers and raised its alleged defenses less than one week prior to the mediation. (Id, ¶ 25). Improvita did not provide supporting documentation. (Id, ¶28). Although the mediation was unsuccessful, the parties attempted to schedule an arbitration. (Id, ¶ 25). Based on correspondence between the parties’ counsel, an arbitration was scheduled for August 19, 2008, before Steve Scott in Phoenix, Arizona. (Id, ¶ 26). However, one week after arbitration was scheduled, Improvita informed MNI that due to a scheduling conflict, the arbitration could not take place before August 26, 2008. (Id, ¶ 27). The parties rescheduled the arbitration for August 27, 2008, to take place before Daniel Nastro. (Id, ¶ 29). The parties also agreed on a disclosure statement date for discovery and relevant arbitration issues; Improvita confirmed the August 27, 2008 arbitration date in a letter dated July 1, 2008. (Id). But on August 14, 2008, Improvita announced that it would not participate in the scheduled arbitration because of the “associated expenses”; it proceeded to cancel the arbitration and offered to reschedule one after October 1, 2008. (Id, ¶ 30). Instead, on October 1, 2008, MNI filed a Complaint against Improvita and Defendants Klamet and Kohler in this Court for breach of contract, viewing Improvita’s cancellation of the arbitration as an act of bad faith and an attempt to further delay resolution. (Dkt. # 1). Defendants filed a Motion to Dismiss on October 6, 2008, and request dismissal pursuant to Federal Rules of Civil Procedure 12(b)(l)(2)(3) and (6). (Dkt. #7). On November 24, 2008, 2008 WL 5068935, the Court granted the Defendants’ Motion to Dismiss without prejudice and ordered the Parties to submit to arbitration no later than December 23, 2008. (Dkt. # 16). The Court further ordered that if the arbitration did not occur within the specified time, it would permit the Plaintiff to file a motion to re-open the case. (Id).

On December 02, 2008, Improvita filed a Motion to Continue Arbitration. (Dkt. # 18). The Court denied the Defendants’ motion, ordering the parties to meet and confer to select an arbitrator no later than December 12, 2008. (Dkt. # 20). On January 27, 2009, MNI filed a Motion to ReOpen the Case, alleging that Defendants refused to arbitrate the dispute by the court-ordered date, (Dkt. # 21), along with its First Amended Complaint. (Dkt. # 22). In response, on February 13, 2009, Defendants filed the following with the Court: Response to Plaintiffs Motion to Re-Open the Case, (Dkt. #23), Separate Answer to Amended Complaint by Improvita Health Products, Inc., (Dkt. #24), Separate Answer to Amended Complaint by Thomas Klamet, Daniel Kohler, (Dkt. # 25), Motion For Judgement on the Pleadings pursuant to Rule 12(c) of the Federal Rules of Civil Procedure. (Dkt. # 26). The Court granted the MNI’s Motion to Re-Open on February 17, 2009.

In the instant motion before the Court— Defendant’s Motion For Judgement on the Pleadings pursuant to Rule 12(c) of the Federal Rules of Civil Procedure—Individual Defendants Klamet and Kohler contend that judgement on the pleadings is *846 appropriate because their status as corporate officers shields them from personal liability with regards to Plaintiffs claims. (Id.). Additionally, these Defendants argue that the Court may not exercise jurisdiction over them. (Id.). Plaintiff, on the other hand, counters that its pleadings properly allege actionable claims and make a prima facie showing of personal jurisdiction over Defendants Klamet and Kohler. (Dkt. # 28).

II: DEFENDANTS’ MOTION FOR JUDGEMENT ON THE PLEADINGS:

A. Standard:

Rule 12(c) of the Federal Rules of Civil Procedure

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Villalobos v. Shinn
D. Arizona, 2022
Williams v. Wiggins
D. Arizona, 2019
National Fire Insurance v. Lewis
898 F. Supp. 2d 1132 (D. Arizona, 2012)
NIKE, INC. v. Lombardi
732 F. Supp. 2d 1146 (D. Oregon, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
663 F. Supp. 2d 841, 2009 U.S. Dist. LEXIS 95869, 2009 WL 3188416, Counsel Stack Legal Research, https://law.counselstack.com/opinion/marlyn-nutraceuticals-inc-v-improvita-health-products-azd-2009.